Media

Filter by Category

All Blog News Podcasts Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

January 17, 2025

FDA Accepts Qualification Plan for Urine Biomarker Panel to Allow Earlier Detection of Response to Drug-Induced Kidney Injury in Clinical Trials

The Foundation for the National Institutes of Health (FNIH) and Critical Path Institute® (C-Path)...

January 17, 2025

A public forum for stakeholders Critical Path Institute's (C-Path) Critical Path for Rare and Neurodegenerative Diseases...

January 15, 2025

C-Path is excited to welcome Bayer Pharma as a the newest member of the organization's Critical Path for Parkinson’s (CPP)...

January 14, 2025

C-Path and TRxA today officially launched its 2025 global Request for Proposals for Bridging Research...

January 12, 2025

Every year on January 12th, we pause to celebrate National Pharmacist Day — a day dedicated to recognizing the vital role...

January 7, 2025

The value of involving people living with diseases in the research process is increasingly recognized...

December 13, 2024

In the rapidly evolving landscape of healthcare and drug development, the ability to efficiently collect...

December 12, 2024

This event featured Dr. Volker Straub, a renowned neuromuscular genetics expert...

November 27, 2024

Autosomal Recessive Polycystic Kidney Disease (ARPKD) is a rare genetic disease. It occurs in about one in 20,000 births...

November 27, 2024

The mission of the Polycystic Kidney Disease Foundation is to fund research, advocate for patients, and ultimately to end PKD..